-
Elevance Health set to acquire BCBS Louisiana
Elevance Health will acquire Blue Cross and Blue Shield of Louisiana, adding the Baton Rouge-based payer's 1.9 million members to its Anthem Blue Cross brand. -
Centene finalizes divestiture of Magellan Specialty Health
Centene has completed its divestiture of Magellan Specialty Health to healthcare administration company Evolent Health. -
UnitedHealth facing UK antitrust probe
The U.K.'s Competition and Markets Authority is investigating UnitedHealth Group's proposed acquisition of the health technology firm EMIS Group, Seeking Alpha reported Jan. 20. -
Sentara boosts health plan membership by 200K with AvMed purchase
Sentara Healthcare has finalized its acquisition of nonprofit health plan AvMed. -
7 recent payer M&A updates
From the merging of two payers to multibillion-dollar acquisitions, these are seven M&A updates involving payers reported by Becker's since Nov. 17: -
BCBS Michigan completes acquisition of commercial underwriting company AmeriTrust
BCBS Michigan subsidiary AF Group completed its purchase of Southfield, Mich.-based AmeriTrust Group for an undisclosed amount on Jan. 3. -
An 'arms race': 10 payer M&A deals to know from 2022
An analyst likened the current payer merger and acquisition environment to an "arms race," during a Nov. 3 Cigna investor call. -
SCAN Group, CareOregon to combine
Two nonprofit payers, SCAN Group and CareOregon, plan to combine under the name HealthRight group. -
6 Optum provider purchases in 2022
From a planned buy of home health firm LHC Group for $5.4 billion to previously undisclosed purchases in Oregon, these are six provider acquisitions by Optum reported by Becker's in 2022: -
UnitedHealth's LHC Group acquisition delayed until 2023
Previously expected to close by the end of 2022, United Health Group's acquisition of home-health firm LHC Group will now likely be finalized in the first quarter of 2023, according to an LHC filing with the Securities and Exchange Commission. -
Centene completes sale of MagellanRx to Prime Therapeutics
Centene has finalized divestiture of pharmaceutical benefit manager, MagellanRx, to Prime Therapeutics, the company said Dec. 5. -
5 major Centene deals in 2022
Centene announced Nov. 17 it is selling Magellan Specialty Health, the latest in a number of deals the health insurer has made throughout 2022. -
Centene completes sale of Spanish, central European businesses
Centene said in a Nov. 17 news release it has completed the sale of its Spanish and central European businesses to Vivalto Santé, a French private hospital group. -
Centene selling Magellan Specialty Health in $750M deal
Centene is selling Magellan Specialty Health to healthcare administration company Evolent Health in a deal worth up to $750 million. -
CareMax closes on deal for value-based Medicare members from Steward Health Care
Senior healthcare provider CareMax has acquired Dallas-based Steward Health Care's Medicare value-based care business in a cash and stock deal. -
6 recent payer mergers and acquisitions
Here are six payer merger and acquisition updates Becker's has reported since Oct. 17. -
Why Cigna invested in VillageMD's Summit Health acquisition
Cigna's health services arm Evernorth will be a minority owner in VillageMD after it invested in the primary care disruptor's acquisition of Summit Health. -
Elevance Health to acquire specialty pharmacy BioPlus
Elevance Health will acquire the nation's largest independent specialty pharmacy, BioPlus. -
UnitedHealth Group acquisition of LHC Group may close in December: report
UnitedHealth Group's acquisition of Lafayette, La.-based home-health firm LHC Group is on track to be completed in December, Seeking Alpha reported Nov. 8. -
'Do you not see this as an arms race?' Cigna CEO questioned on M&A activity
Cigna's CEO David Cordani addressed questions from investors Nov. 3 over concerns the company is falling behind other insurers by not pursuing major mergers or acquisitions.
Page 9 of 50